Global Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

According to APO Research, The global Radiopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Radiopharmaceuticals include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Radiopharmaceuticals segment by Company

Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Radiopharmaceuticals segment by Type

Diagnostic Radioisotopes
Therapeutic Radioisotopes
Radiopharmaceuticals segment by Application

Oncology
Cardiology
Other
Radiopharmaceuticals segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Radiopharmaceuticals Market Size, 2019 VS 2023 VS 2030
1.3 Global Radiopharmaceuticals Market Size Estimates and Forecasts (2019-2030)
1.4 Global Radiopharmaceuticals Sales Estimates and Forecasts (2019-2030)
1.5 Global Radiopharmaceuticals Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Radiopharmaceuticals Market Dynamics
2.1 Radiopharmaceuticals Industry Trends
2.2 Radiopharmaceuticals Industry Drivers
2.3 Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Radiopharmaceuticals Industry Restraints
3 Radiopharmaceuticals Market by Manufacturers
3.1 Global Radiopharmaceuticals Revenue by Manufacturers (2019-2024)
3.2 Global Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.3 Global Radiopharmaceuticals Average Sales Price by Manufacturers (2019-2024)
3.4 Global Radiopharmaceuticals Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Radiopharmaceuticals Manufacturers, Product Type & Application
3.7 Global Radiopharmaceuticals Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Radiopharmaceuticals Market CR5 and HHI
3.8.2 Global Top 5 and 10 Radiopharmaceuticals Players Market Share by Revenue in 2023
3.8.3 2023 Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals Market by Type
4.1 Radiopharmaceuticals Type Introduction
4.1.1 Diagnostic Radioisotopes
4.1.2 Therapeutic Radioisotopes
4.2 Global Radiopharmaceuticals Sales by Type
4.2.1 Global Radiopharmaceuticals Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceuticals Sales by Type (2019-2030)
4.2.3 Global Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.3 Global Radiopharmaceuticals Revenue by Type
4.3.1 Global Radiopharmaceuticals Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceuticals Revenue by Type (2019-2030)
4.3.3 Global Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
5 Radiopharmaceuticals Market by Application
5.1 Radiopharmaceuticals Application Introduction
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceuticals Sales by Application
5.2.1 Global Radiopharmaceuticals Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceuticals Sales by Application (2019-2030)
5.2.3 Global Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.3 Global Radiopharmaceuticals Revenue by Application
5.3.1 Global Radiopharmaceuticals Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Radiopharmaceuticals Revenue by Application (2019-2030)
5.3.3 Global Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
6 Global Radiopharmaceuticals Sales by Region
6.1 Global Radiopharmaceuticals Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Radiopharmaceuticals Sales by Region (2019-2030)
6.2.1 Global Radiopharmaceuticals Sales by Region (2019-2024)
6.2.2 Global Radiopharmaceuticals Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Radiopharmaceuticals Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Radiopharmaceuticals Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Radiopharmaceuticals Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Radiopharmaceuticals Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Radiopharmaceuticals Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Radiopharmaceuticals Revenue by Region
7.1 Global Radiopharmaceuticals Revenue by Region
7.1.1 Global Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Radiopharmaceuticals Revenue by Region (2019-2024)
7.1.3 Global Radiopharmaceuticals Revenue by Region (2025-2030)
7.1.4 Global Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Radiopharmaceuticals Revenue (2019-2030)
7.2.2 North America Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Radiopharmaceuticals Revenue (2019-2030)
7.3.2 Europe Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Radiopharmaceuticals Revenue (2019-2030)
7.4.2 Asia-Pacific Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Radiopharmaceuticals Revenue (2019-2030)
7.5.2 LAMEA Radiopharmaceuticals Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Bracco Imaging
8.1.1 Bracco Imaging Comapny Information
8.1.2 Bracco Imaging Business Overview
8.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
8.1.5 Bracco Imaging Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Bayer Radiopharmaceuticals Product Portfolio
8.2.5 Bayer Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Nordion
8.4.1 Nordion Comapny Information
8.4.2 Nordion Business Overview
8.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Nordion Radiopharmaceuticals Product Portfolio
8.4.5 Nordion Recent Developments
8.5 Triad Isotopes
8.5.1 Triad Isotopes Comapny Information
8.5.2 Triad Isotopes Business Overview
8.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
8.5.5 Triad Isotopes Recent Developments
8.6 Lantheus
8.6.1 Lantheus Comapny Information
8.6.2 Lantheus Business Overview
8.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Lantheus Radiopharmaceuticals Product Portfolio
8.6.5 Lantheus Recent Developments
8.7 IBA Group
8.7.1 IBA Group Comapny Information
8.7.2 IBA Group Business Overview
8.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 IBA Group Radiopharmaceuticals Product Portfolio
8.7.5 IBA Group Recent Developments
8.8 GE Healthcare
8.8.1 GE Healthcare Comapny Information
8.8.2 GE Healthcare Business Overview
8.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
8.8.5 GE Healthcare Recent Developments
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Comapny Information
8.9.2 China Isotope & Radiation Business Overview
8.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
8.9.5 China Isotope & Radiation Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
8.11.5 Eli Lilly Recent Developments
8.12 Advanced Accelerator Applications
8.12.1 Advanced Accelerator Applications Comapny Information
8.12.2 Advanced Accelerator Applications Business Overview
8.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
8.12.5 Advanced Accelerator Applications Recent Developments
8.13 SIEMENS
8.13.1 SIEMENS Comapny Information
8.13.2 SIEMENS Business Overview
8.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
8.13.5 SIEMENS Recent Developments
8.14 Dongcheng
8.14.1 Dongcheng Comapny Information
8.14.2 Dongcheng Business Overview
8.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
8.14.5 Dongcheng Recent Developments
8.15 Navidea
8.15.1 Navidea Comapny Information
8.15.2 Navidea Business Overview
8.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Navidea Radiopharmaceuticals Product Portfolio
8.15.5 Navidea Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Radiopharmaceuticals Value Chain Analysis
9.1.1 Radiopharmaceuticals Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Radiopharmaceuticals Production Mode & Process
9.2 Radiopharmaceuticals Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Radiopharmaceuticals Distributors
9.2.3 Radiopharmaceuticals Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings